Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 09:00 am Purchase | 13G | CASTLE BIOSCIENCES INC CSTL | Granahan Investment Management LLC | 2,166,471 8.05% | 2,166,471 (New Position) | View |
| 2024-02-13 5:01 pm Purchase | 13G | CASTLE BIOSCIENCES INC CSTL | VANGUARD GROUP INC | 1,461,481 5.43% | 68,757 (+4.94%) | View |
| 2024-02-13 2:07 pm Purchase | 13G | CASTLE BIOSCIENCES INC CSTL | PRINCIPAL GLOBAL INVESTORS | 1,585,639 5.89% | 1,585,639 (New Position) | View |
| 2024-02-09 12:43 pm Sale | 13G | CASTLE BIOSCIENCES INC CSTL | WASATCH ADVISORS LP | 2,590,951 9.6% | -631,611 (-19.60%) | View |
| 2024-01-25 1:48 pm Purchase | 13G | CASTLE BIOSCIENCES INC CSTL | BlackRock Inc. BLK | 2,283,199 8.5% | 159,511 (+7.51%) | View |
| 2023-02-09 5:21 pm Purchase | 13G | CASTLE BIOSCIENCES INC CSTL | WASATCH ADVISORS LP | 3,222,562 12.2% | 106,074 (+3.40%) | View |
| 2023-02-09 11:12 am Purchase | 13G | CASTLE BIOSCIENCES INC CSTL | VANGUARD GROUP INC | 1,392,724 5.29% | 1,392,724 (New Position) | View |
| 2023-02-03 4:27 pm Purchase | 13G | CASTLE BIOSCIENCES INC CSTL | BlackRock Inc. BLK | 2,123,688 8.1% | 322,301 (+17.89%) | View |
| 2022-02-11 4:01 pm Sale | 13G | CASTLE BIOSCIENCES INC CSTL | MAETZOLD DEREK J | 1,022,068 4% | -633,207 (-38.25%) | View |
| 2022-02-10 5:23 pm Purchase | 13G | CASTLE BIOSCIENCES INC CSTL | WASATCH ADVISORS LP | 3,116,488 12.3% | 609,423 (+24.31%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | CASTLE BIOSCIENCES INC CSTL | BlackRock Inc. BLK | 1,801,387 7.1% | 1,801,387 (New Position) | View |
| 2021-06-10 11:46 am Purchase | 13G | CASTLE BIOSCIENCES INC CSTL | WASATCH ADVISORS LP | 2,507,065 10% | 442,234 (+21.42%) | View |
| 2021-02-16 9:56 pm Sale | 13G | CASTLE BIOSCIENCES INC CSTL | BRADBURY DANIEL | 743,420 3% | -165,158 (-18.18%) | View |
| 2021-02-16 9:44 pm Sale | 13G | CASTLE BIOSCIENCES INC CSTL | MAETZOLD DEREK J | 1,655,275 6.62% | -297,940 (-15.25%) | View |
| 2021-02-16 4:11 pm Sale | 13G | CASTLE BIOSCIENCES INC CSTL | MGC Venture Partners 2013 GP LLC | 741,305 3.1% | -1,213,603 (-62.08%) | View |
| 2021-02-12 4:05 pm Sale | 13G | CASTLE BIOSCIENCES INC CSTL | Industry Ventures Healthcare LLC | 0 0% | -1,253,493 (Position Closed) | View |
| 2021-02-11 1:32 pm Purchase | 13G | CASTLE BIOSCIENCES INC CSTL | WASATCH ADVISORS LP | 2,064,831 8.4% | 2,064,831 (New Position) | View |
| 2021-02-10 4:37 pm Purchase | 13G | CASTLE BIOSCIENCES INC CSTL | ARK Investment Management LLC | 2,552,497 10.44% | 2,552,497 (New Position) | View |
| 2020-10-08 8:57 pm Sale | 13D | CASTLE BIOSCIENCES INC CSTL | Sofinnova HealthQuest Partners L.P. | 983,577 4.997% | -200,000 (-16.90%) | View |
| 2020-07-13 6:45 pm Sale | 13D | CASTLE BIOSCIENCES INC CSTL | Sofinnova HealthQuest Partners L.P. | 1,183,577 6% | -50,000 (-4.05%) | View |